Market Cap (In INR)
211.31 Billion
Revenue (In INR)
22.26 Billion
Net Income (In INR)
3.57 Billion
Avg. Volume
214.5 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1943.7-3653.95
- PE
- 50.72
- EPS
- 50.0
- Beta Value
- 0.297
- ISIN
- INE600L01024
- CUSIP
- Y2R0AQ143
- CIK
- -
- Shares
- 83326975.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Shankha Banerjee
- Employee Count
- -
- Website
- https://www.lalpathlabs.com
- Ipo Date
- 2015-12-23
- Details
- Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.
More Stocks
-
ZLIOY
-
APRE
-
TRCNF
-
PRABHHANSPRABHHANS INDUSTRIES LIMITED
PRABHHANS
-
GRINDWELLGrindwell Norton Limited
GRINDWELL
-
0HOBH&R Block, Inc.
0HOB
-
0U3QInterDigital, Inc.
0U3Q
-
YUYü Group PLC
YU